Kimberly-Clark to buy maker of Tylenol
Digest more
If you bought Infants' Tylenol in the last five years, you could have money coming your way. Johnson and Johnson has agreed to pay up to $6.3 million to customers who bought Infants' Tylenol since 2014. The settlement is in response to a class-action ...
Kimberly-Clark, which owns brands like Kleenex and Huggies, is set to acquire Kenvue, the consumer health company that owns Tylenol, through an almost $49 billion deal. The deal comes after Kenvue faced financial and legal struggles—even parting ways with its CEO in July after its stock sharply dropped—thanks to U.
Every time Samuel publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
TONIGHT AND HEALTH SECRETARY ROBERT F KENNEDY JR IS DOUBLING DOWN ON HIS CLAIMS ABOUT TYLENOL AND ITS LINKED TO AUTISM. IT WAS LAST MONTH THE TRUMP ADMINISTRATION WARNED PREGNANT WOMEN NOT TO TAKE ACETAMINOPHEN, SAYING THAT USAGE DURING PREGNANCY MAY BE ...
Shares of Kenvue fell more than 10% on Friday after a report that Health Secretary Robert F. Kennedy Jr. will likely link autism to the use of the company’s pain medication Tylenol in pregnant women. HHS will release the report that could draw that link ...
Health and Human Services Secretary Robert F. Kennedy Jr. said that giving Tylenol to infant boys after circumcision could be a cause of autism among males. Kennedy and President Donald Trump, during Thursday’s Cabinet meeting, briefly discussed the ...
The fever reducer is often given to infants and kids. But Monday’s announcement left some families confused after the president discouraged the drug’s use during pregnancy and in newborns. Now pediatricians are weighing in with some advice. “Don’t ...
Health and Human Services Secretary Robert F. Kennedy Jr. has said that there is not sufficient evidence to claim that Tylenol causes autism a month after the White House discouraged its use among pregnant women.
Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a massive consumer products conglomerate.
Feedback